Fragasso Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $378K | Buy |
2,989
+155
| +5% | +$20.4K | 0.02% | 250 |
|
|
2026
Q1 | $397K | Buy |
2,834
+528
| +23% | +$73.9K | 0.02% | 228 |
|
|
2025
Q4 | $283K | Buy |
2,306
+146
| +7% | +$17.7K | 0.02% | 255 |
|
|
2025
Q3 | $243K | Sell |
2,160
-3
| -0.1% | -$341 | 0.02% | 259 |
|
|
2025
Q2 | $240K | Buy |
2,163
+303
| +16% | +$32.2K | 0.02% | 248 |
|
|
2025
Q1 | $208K | Buy |
+1,860
| New | +$192K | 0.02% | 251 |
|
|
2024
Q3 | – | Sell |
-3,160
| Closed | -$217K | – | 270 |
|
|
2024
Q2 | $217K | Sell |
3,160
-211
| -6% | -$14.1K | 0.02% | 249 |
|
|
2024
Q1 | $247K | Buy |
3,371
+105
| +3% | +$8.07K | 0.02% | 233 |
|
|
2023
Q4 | $265K | Buy |
3,266
+361
| +12% | +$28.1K | 0.02% | 214 |
|
|
2023
Q3 | $218K | Sell |
2,905
-105
| -3% | -$8.08K | 0.02% | 213 |
|
|
2023
Q2 | $232K | Buy |
3,010
+114
| +4% | +$9.09K | 0.02% | 212 |
|
|
2023
Q1 | $240K | Buy |
2,896
+281
| +11% | +$23.3K | 0.03% | 195 |
|
|
2022
Q4 | $224K | Buy |
+2,615
| New | +$207K | 0.03% | 193 |
|
|
2020
Q2 | – | Sell |
-4,612
| Closed | -$345K | – | 117 |
|
|
2020
Q1 | $345K | Sell |
4,612
-34,076
| -88% | -$2.35M | 0.08% | 93 |
|
|
2019
Q4 | $2.51M | Sell |
38,688
-4,100
| -10% | -$267K | 0.42% | 56 |
|
|
2019
Q3 | $2.71M | Buy |
42,788
+930
| +2% | +$60.8K | 0.5% | 51 |
|
|
2019
Q2 | $2.83M | Buy |
41,858
+2,036
| +5% | +$134K | 0.56% | 50 |
|
|
2019
Q1 | $2.59M | Buy |
39,822
+17,089
| +75% | +$1.14M | 0.55% | 52 |
|
|
2018
Q4 | $1.42M | Sell |
22,733
-13
| -0.1% | -$909 | 0.32% | 63 |
|
|
2018
Q3 | $1.6M | Buy |
22,746
+5,563
| +32% | +$420K | 0.39% | 52 |
|
|
2018
Q2 | $1.22M | Buy |
17,183
+30
| +0.2% | +$2.12K | 0.31% | 55 |
|
|
2018
Q1 | $1.29M | Buy |
17,153
+2,408
| +16% | +$191K | 0.32% | 52 |
|
|
2017
Q4 | $1.06M | Buy |
14,745
+1,000
| +7% | +$75.9K | 0.26% | 62 |
|
|
2017
Q3 | $1.11M | Sell |
13,745
-4,081
| -23% | -$312K | 0.34% | 50 |
|
|
2017
Q2 | $1.26M | Buy |
17,826
+607
| +4% | +$40.4K | 0.38% | 40 |
|
|
2017
Q1 | $1.17M | Buy |
17,219
+1,691
| +11% | +$119K | 0.37% | 40 |
|
|
2016
Q4 | $1.11M | Buy |
15,528
+1,221
| +9% | +$90.8K | 0.37% | 45 |
|
|
2016
Q3 | $1.13M | Buy |
14,307
+420
| +3% | +$34.1K | 0.4% | 34 |
|
|
2016
Q2 | $1.16M | Buy |
13,887
+476
| +4% | +$42.2K | 0.43% | 33 |
|
|
2016
Q1 | $1.23M | Sell |
13,411
-35
| -0.3% | -$3.16K | 0.48% | 27 |
|
|
2015
Q4 | $1.36M | Hold |
13,446
| – | – | 0.52% | 26 |
|
|
2015
Q3 | $1.32M | Buy |
+13,446
| New | +$1.49M | 0.52% | 24 |
|
|
2015
Q2 | – | Sell |
-13,196
| Closed | -$1.29M | – | 42 |
|
|
2015
Q1 | $1.29M | Buy |
+13,196
| New | +$1.34M | 0.51% | 25 |
|
Other funds holding GILD
Fragasso Financial Advisors's GILD Position: Q2 2026 in Review
Fragasso Financial Advisors increased its Gilead Sciences (GILD) stake by 5.5% in Q2 2026, buying an estimated $20.4K and bringing the position to 2,989 shares worth $378K. The position accounts for 0.02% of the portfolio, ranked #250.
Fragasso Financial Advisors first reported a position in GILD in Q1 2015 and has held it in 33 quarters since. The position peaked at $2.83M in Q2 2019. 1,065 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Fragasso Financial Advisors held 2,989 shares of Gilead Sciences worth $378K as of Q2 2026.
- Fragasso Financial Advisors bought 155 Gilead Sciences shares in Q2 2026, an estimated $20.4K.
- Gilead Sciences made up 0.02% of Fragasso Financial Advisors's portfolio in Q2 2026, its #250 holding.
- Fragasso Financial Advisors first reported a position in Gilead Sciences in Q1 2015 and has held it in 33 quarters since.
- Fragasso Financial Advisors's Gilead Sciences position peaked at $2.83M in Q2 2019.
- 1,065 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.